Pluristem Launches Co-CEO Structure and Appoints New CFO
Pluristem Therapeutics Inc., a leading developer of placenta-based cell therapy products, announced today two senior executive appointments to support the company's growth and ensure continued success as it enters advanced stages of clinical development for its PLX products.
View full press release